Caprotec Bioanalytics

About:

Caprotec Bioanalytics caters to the pharmaceutical, agrochemical, and biotech industries with a proprietary capture protein technology.

Website: http://www.caprotec.com

Twitter/X: criverlabs/

Top Investors: KfW, IBB Ventures, Creathor Ventures, VC Fonds Technologie Berlin, ERP Startfonds

Description:

caprotec bioanalytics has developed a ground-breaking, proprietary technology to reduce the complexity of protein mixtures and samples in a targeted and directed manner. caprotec's Capture Compound Mass Spectrometry (CCMS) Technology is based on multifunctional small molecules (Capture Compoundsâ„¢) that are used to target, capture, and isolate proteins based on their functionality. For many applications, CCMS is clearly superior to shotgun approaches - thus addressing an unmet need in the proteomics community.